Immuneai-CMV (Phase 1): Precision Phenotyping Reveals Heterogeneous CMV–GVHD Trade-Offs Following Allogeneic HCT

Key Points

• The analysis uncovers heterogeneous trade-offs between CMV infection and GVHD outcomes.
• Key findings highlight variable immune responses linked to CMV in a subset of patients.
• Observational analysis highlights distinct immune response patterns after allogeneic hematopoietic cell transplantation.
• These insights may guide personalized treatment strategies for managing CMV risks in transplant patients.